BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 26157003)

  • 1. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
    Lee SH; Ledri M; Tóth B; Marchionni I; Henstridge CM; Dudok B; Kenesei K; Barna L; Szabó SI; Renkecz T; Oberoi M; Watanabe M; Limoli CL; Horvai G; Soltesz I; Katona I
    J Neurosci; 2015 Jul; 35(27):10039-57. PubMed ID: 26157003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus.
    Neu A; Földy C; Soltesz I
    J Physiol; 2007 Jan; 578(Pt 1):233-47. PubMed ID: 17053036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depolarizing GABAergic synaptic input triggers endocannabinoid-mediated retrograde synaptic signaling.
    Urbanski MJ; Kovacs FE; Szabo B
    Synapse; 2009 Aug; 63(8):643-52. PubMed ID: 19347961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.
    Sheinin A; Talani G; Davis MI; Lovinger DM
    J Neurophysiol; 2008 Aug; 100(2):1041-52. PubMed ID: 18497350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1.
    Ali AB; Todorova M
    Eur J Neurosci; 2010 Apr; 31(7):1196-207. PubMed ID: 20345910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation.
    Inada H; Maejima T; Nakahata Y; Yamaguchi J; Nabekura J; Ishibashi H
    Neuroscience; 2010 Feb; 165(4):1377-89. PubMed ID: 19961906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.
    Pan B; Wang W; Long JZ; Sun D; Hillard CJ; Cravatt BF; Liu QS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):591-7. PubMed ID: 19666749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.
    Di S; Itoga CA; Fisher MO; Solomonow J; Roltsch EA; Gilpin NW; Tasker JG
    J Neurosci; 2016 Aug; 36(32):8461-70. PubMed ID: 27511017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
    Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
    J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus.
    Lee SH; Földy C; Soltesz I
    J Neurosci; 2010 Jun; 30(23):7993-8000. PubMed ID: 20534847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
    Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
    Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons.
    Farkas I; Kalló I; Deli L; Vida B; Hrabovszky E; Fekete C; Moenter SM; Watanabe M; Liposits Z
    Endocrinology; 2010 Dec; 151(12):5818-29. PubMed ID: 20926585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
    Lau BK; Drew GM; Mitchell VA; Vaughan CW
    Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel non-CB1/TRPV1 endocannabinoid-mediated mechanism depresses excitatory synapses on hippocampal CA1 interneurons.
    Edwards JG; Gibson HE; Jensen T; Nugent F; Walther C; Blickenstaff J; Kauer JA
    Hippocampus; 2012 Feb; 22(2):209-21. PubMed ID: 21069781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses.
    Kim J; Alger BE
    Nat Neurosci; 2010 May; 13(5):592-600. PubMed ID: 20348918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid signaling in inhibitory autaptic hippocampal neurons.
    Straiker A; Mackie K
    Neuroscience; 2009 Sep; 163(1):190-201. PubMed ID: 19501632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymodal activation of the endocannabinoid system in the extended amygdala.
    Puente N; Cui Y; Lassalle O; Lafourcade M; Georges F; Venance L; Grandes P; Manzoni OJ
    Nat Neurosci; 2011 Nov; 14(12):1542-7. PubMed ID: 22057189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity.
    Adermark L; Talani G; Lovinger DM
    Eur J Neurosci; 2009 Jan; 29(1):32-41. PubMed ID: 19120438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.